JYSB2300210 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Supplementary Application | 2023-12-09 | | | | | view |
JXSS2101020 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products(3.1) | Import Drug Application | 2021-09-15 | | | | | view |
JXSL2000061 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Import Drug Application | 2020-05-30 | | Bristol-Myers Squibb Company | In Review | 2020-05-29 | view |
JXSS1900038 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Import Drug Application | 2019-07-03 | | | Certificate Issued | 2020-03-12 | view |
JXSB2101075 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Supplementary Application | 2021-10-22 | | | | | view |
JXSL2000151 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products(2.2) | Import Drug Application | 2020-09-14 | | Bristol-Myers Squibb Company | In Review | 2020-09-11 | view |
JYSB1900287 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Supplementary Application | 2019-10-18 | | | In Review | 2019-10-17 | view |
JYSB2101135 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Supplementary Application | 2021-09-15 | | | | | view |
JXSL2000010 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Import Drug Application | 2020-01-21 | | Bristol-Myers Squibb Company | In Review | 2020-01-20 | view |
JXSS1900001 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Import Drug Application | 2019-02-11 | | | Certificate Issued | 2019-10-15 | view |
JXSS2400015 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-02-24 | | | | | view |
JXSS2101027 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products(3.1) | Import Drug Application | 2021-10-29 | | | | | view |
JYSB2000327 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Supplementary Application | 2020-07-04 | | | Certificate Issued | 2020-08-11 | view |
JXSL1900069 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Import Drug Application | 2019-08-24 | | Bristol-Myers Squibb Company | In Review | 2019-08-23 | view |
JXSS2101019 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products(3.1) | Import Drug Application | 2021-09-15 | | | | | view |
JXSL1900150 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Import Drug Application | 2019-12-21 | | Bristol-Myers Squibb Company | In Review | 2019-12-20 | view |
JYSB2000104 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Supplementary Application | 2020-04-09 | | | Certificate Issued | 2020-12-30 | view |
JXSL1900033 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Import Drug Application | 2019-03-27 | | Bristol-Myers Squibb Pharma Eeig | In Review | 2019-03-26 | view |
JXSL2101138 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-11-24 | | | | | view |
JYSB2000330 | 纳武利尤单抗注射液 | nivolumab | Injection | Biological Products | Supplementary Application | 2020-07-04 | | | Certificate Issued | 2020-08-07 | view |